Shigenori Kadowaki Selected Research

Shigenori Kadowaki Research Topics

Disease

41	Neoplasms (Cancer) 10/2023 - 06/2004
32	Stomach Neoplasms (Stomach Cancer) 04/2024 - 07/2012
23	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 06/2009
12	Adenocarcinoma 06/2023 - 01/2016
12	Esophageal Squamous Cell Carcinoma 01/2023 - 11/2013
9	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2009
8	Disease Progression 01/2023 - 01/2013
6	Neutropenia 11/2023 - 11/2013
5	Squamous Cell Carcinoma of Head and Neck 03/2024 - 04/2009
5	Ascites 01/2023 - 06/2009
5	Esophageal Neoplasms (Esophageal Cancer) 02/2021 - 08/2015
3	Febrile Neutropenia 11/2023 - 01/2017
3	Diarrhea 11/2020 - 11/2011
3	Mucositis 11/2020 - 11/2011
3	Anorexia 01/2019 - 04/2009
3	Leukopenia 01/2019 - 04/2009
3	Nausea 01/2017 - 04/2009
3	Stomatitis 11/2013 - 04/2009
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 11/2019
2	Microsatellite Instability 02/2021 - 01/2019
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 11/2020 - 01/2019
2	Anemia 01/2019 - 01/2017
2	Brain Diseases (Brain Disorder) 01/2019 - 06/2017
2	Hypertension (High Blood Pressure) 01/2019 - 01/2017
2	Thrombocytopenia (Thrombopenia) 01/2019 - 01/2017
2	Head and Neck Neoplasms (Head and Neck Cancer) 11/2018 - 04/2009
2	Sarcopenia 10/2018 - 06/2017
2	Disseminated Intravascular Coagulation 09/2017 - 01/2017
2	Carcinoma (Carcinomatosis) 01/2013 - 04/2006
1	Nasopharyngeal Carcinoma 03/2024
1	Thyroid Neoplasms (Thyroid Cancer) 02/2024
1	Rectal Neoplasms (Rectal Cancer) 01/2023
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	Hemolytic Anemia 01/2022
1	Sepsis (Septicemia) 01/2022
1	Liver Failure 01/2022
1	Sudden Death 01/2022

Drug/Important Bio-Agent (IBA)

16	Fluorouracil (Carac)FDA LinkGeneric 03/2024 - 09/2004
15	NivolumabIBA 06/2023 - 11/2018
14	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2024 - 02/2014
14	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 04/2009
11	Leucovorin (Folinic Acid)FDA Link 03/2023 - 09/2004
10	Irinotecan (Camptosar)FDA LinkGeneric 11/2023 - 06/2009
10	Bevacizumab (Avastin)FDA Link 11/2023 - 02/2014
9	PlatinumIBA 01/2023 - 01/2017
8	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2017
8	Trastuzumab (Herceptin)FDA Link 04/2024 - 01/2013
7	Cetuximab (Erbitux)FDA Link 03/2024 - 06/2009
6	Immune Checkpoint InhibitorsIBA 10/2023 - 11/2019
6	Taxoids (Taxanes)IBA 06/2023 - 11/2018
6	RamucirumabIBA 01/2023 - 01/2018
6	S-1 plus cisplatinIBA 01/2022 - 07/2012
5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2016
5	human ERBB2 proteinIBA 01/2022 - 01/2016
5	regorafenibIBA 11/2019 - 01/2017
4	trifluridine tipiracil drug combinationIBA 11/2023 - 01/2017
4	Paclitaxel (Taxol)FDA LinkGeneric 07/2021 - 01/2018
4	Docetaxel (Taxotere)FDA Link 02/2021 - 11/2013
3	taxaneIBA 01/2023 - 09/2017
3	BilirubinIBA 01/2019 - 01/2016
3	AntibodiesIBA 11/2018 - 12/2012
3	Epidermal Growth Factor (EGF)IBA 01/2014 - 12/2012
2	pembrolizumabIBA 03/2024 - 12/2021
2	Gemcitabine FDA Link 03/2024 - 09/2004
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2023 - 07/2023
2	130-nm albumin-bound paclitaxelIBA 01/2023 - 09/2017
2	Growth Factor ReceptorsIBA 01/2023 - 03/2016
2	Monoclonal AntibodiesIBA 01/2023 - 01/2022
2	andecaliximabIBA 01/2022 - 01/2022
2	Cytotoxins (Cytolysins)IBA 04/2020 - 08/2017
2	Panitumumab (Vectibix)FDA Link 01/2020 - 03/2016
2	Dacarbazine (DIC)FDA LinkGeneric 09/2017 - 01/2017
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017 - 01/2017
2	ParaffinIBA 01/2016 - 06/2004
1	B7-H1 AntigenIBA 03/2024
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2024
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 02/2024
1	binimetinibIBA 02/2024
1	encorafenibIBA 02/2024
1	Dihydrotachysterol (AT 10)IBA 02/2024
1	Antineoplastic Agents (Antineoplastics)IBA 08/2023
1	TropomyosinIBA 07/2023
1	Phosphotransferases (Kinase)IBA 07/2023
1	Albumin-Bound Paclitaxel FDA Link 01/2023
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2022
1	EnzymesIBA 01/2022
1	Capecitabine (Xeloda)FDA Link 01/2022
1	quinone (benzoquinone)IBA 11/2021
1	Oxidoreductases (Dehydrogenase)IBA 11/2021
1	NAD (NADH)IBA 11/2021

Therapy/Procedure

54	Drug Therapy (Chemotherapy) 03/2024 - 06/2004
27	Therapeutics 03/2024 - 04/2004
6	Adjuvant Chemotherapy 01/2022 - 09/2004
5	Immunotherapy 10/2023 - 04/2020
5	Chemoradiotherapy 01/2023 - 11/2011
3	Palliative Care (Palliative Therapy) 01/2021 - 01/2007
3	Drug Tapering 06/2017 - 11/2011
3	Neoadjuvant Therapy 10/2016 - 09/2004
2	Combination Drug Therapy (Combination Chemotherapy) 08/2014 - 07/2012
1	Intravenous Infusions 01/2022